Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic
ABSTRACT Chronic infection with hepatitis B and delta viruses (HDV) is the most serious form of viral hepatitis due to more severe manifestations of an accelerated progression to liver fibrosis, cirrhosis, and hepatocellular carcinoma. We characterized early HDV kinetics post-inoculation and incorpo...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2023-08-01
|
Series: | mBio |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mbio.01008-23 |
_version_ | 1797730277940789248 |
---|---|
author | Stephanie Maya Leeor Hershkovich E. Fabian Cardozo-Ojeda Elham Shirvani-Dastgerdi Jay Srinivas Louis Shekhtman Susan L. Uprichard Andrew R. Berneshawi Thomas R. Cafiero Harel Dahari Alexander Ploss |
author_facet | Stephanie Maya Leeor Hershkovich E. Fabian Cardozo-Ojeda Elham Shirvani-Dastgerdi Jay Srinivas Louis Shekhtman Susan L. Uprichard Andrew R. Berneshawi Thomas R. Cafiero Harel Dahari Alexander Ploss |
author_sort | Stephanie Maya |
collection | DOAJ |
description | ABSTRACT Chronic infection with hepatitis B and delta viruses (HDV) is the most serious form of viral hepatitis due to more severe manifestations of an accelerated progression to liver fibrosis, cirrhosis, and hepatocellular carcinoma. We characterized early HDV kinetics post-inoculation and incorporated mathematical modeling to provide insights into host-HDV dynamics. We analyzed HDV RNA serum viremia in 192 immunocompetent (C57BL/6) and immunodeficient (NRG) mice that did or did not transgenically express the HDV receptor—human sodium taurocholate co-transporting polypeptide (hNTCP). Kinetic analysis indicates an unanticipated biphasic decline consisting of a sharp first-phase and slower second-phase decline regardless of immunocompetence. HDV decline after re-inoculation again followed a biphasic decline; however, a steeper second-phase HDV decline was observed in NRG-hNTCP mice compared to NRG mice. HDV-entry inhibitor bulevirtide administration and HDV re-inoculation indicated that viral entry and receptor saturation are not major contributors to clearance, respectively. The biphasic kinetics can be mathematically modeled by assuming the existence of a non-specific-binding compartment with a constant on/off-rate and the steeper second-phase decline by a loss of bound virus that cannot be returned as free virus to circulation. The model predicts that free HDV is cleared with a half-life of 35 minutes (standard error, SE: 6.3), binds to non-specific cells with a rate of 0.05 per hour (SE: 0.01), and returns as free virus with a rate of 0.11 per hour (SE: 0.02). Characterizing early HDV-host kinetics elucidates how quickly HDV is either cleared or bound depending on the immunological background and hNTCP presence. IMPORTANCE The persistence phase of HDV infection has been studied in some animal models; however, the early kinetics of HDV in vivo is incompletely understood. In this study, we characterize an unexpectedly HDV biphasic decline post-inoculation in immunocompetent and immunodeficient mouse models and use mathematical modeling to provide insights into HDV-host dynamics. |
first_indexed | 2024-03-12T11:41:58Z |
format | Article |
id | doaj.art-b9fcc73b41b943d28bbce73d71cfd85d |
institution | Directory Open Access Journal |
issn | 2150-7511 |
language | English |
last_indexed | 2024-03-12T11:41:58Z |
publishDate | 2023-08-01 |
publisher | American Society for Microbiology |
record_format | Article |
series | mBio |
spelling | doaj.art-b9fcc73b41b943d28bbce73d71cfd85d2023-08-31T15:04:20ZengAmerican Society for MicrobiologymBio2150-75112023-08-0114410.1128/mbio.01008-23Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasicStephanie Maya0Leeor Hershkovich1E. Fabian Cardozo-Ojeda2Elham Shirvani-Dastgerdi3Jay Srinivas4Louis Shekhtman5Susan L. Uprichard6Andrew R. Berneshawi7Thomas R. Cafiero8Harel Dahari9Alexander Ploss10Department of Molecular Biology, Princeton University , Princeton, New Jersey, USADepartment of Medicine, The Program for Experimental & Theoretical Modeling, Division of Hepatology, Stritch School of Medicine, Loyola University Chicago , Maywood, Illinois, USADepartment of Medicine, The Program for Experimental & Theoretical Modeling, Division of Hepatology, Stritch School of Medicine, Loyola University Chicago , Maywood, Illinois, USADepartment of Molecular Biology, Princeton University , Princeton, New Jersey, USADepartment of Medicine, The Program for Experimental & Theoretical Modeling, Division of Hepatology, Stritch School of Medicine, Loyola University Chicago , Maywood, Illinois, USADepartment of Medicine, The Program for Experimental & Theoretical Modeling, Division of Hepatology, Stritch School of Medicine, Loyola University Chicago , Maywood, Illinois, USADepartment of Medicine, The Program for Experimental & Theoretical Modeling, Division of Hepatology, Stritch School of Medicine, Loyola University Chicago , Maywood, Illinois, USADepartment of Molecular Biology, Princeton University , Princeton, New Jersey, USADepartment of Molecular Biology, Princeton University , Princeton, New Jersey, USADepartment of Medicine, The Program for Experimental & Theoretical Modeling, Division of Hepatology, Stritch School of Medicine, Loyola University Chicago , Maywood, Illinois, USADepartment of Molecular Biology, Princeton University , Princeton, New Jersey, USAABSTRACT Chronic infection with hepatitis B and delta viruses (HDV) is the most serious form of viral hepatitis due to more severe manifestations of an accelerated progression to liver fibrosis, cirrhosis, and hepatocellular carcinoma. We characterized early HDV kinetics post-inoculation and incorporated mathematical modeling to provide insights into host-HDV dynamics. We analyzed HDV RNA serum viremia in 192 immunocompetent (C57BL/6) and immunodeficient (NRG) mice that did or did not transgenically express the HDV receptor—human sodium taurocholate co-transporting polypeptide (hNTCP). Kinetic analysis indicates an unanticipated biphasic decline consisting of a sharp first-phase and slower second-phase decline regardless of immunocompetence. HDV decline after re-inoculation again followed a biphasic decline; however, a steeper second-phase HDV decline was observed in NRG-hNTCP mice compared to NRG mice. HDV-entry inhibitor bulevirtide administration and HDV re-inoculation indicated that viral entry and receptor saturation are not major contributors to clearance, respectively. The biphasic kinetics can be mathematically modeled by assuming the existence of a non-specific-binding compartment with a constant on/off-rate and the steeper second-phase decline by a loss of bound virus that cannot be returned as free virus to circulation. The model predicts that free HDV is cleared with a half-life of 35 minutes (standard error, SE: 6.3), binds to non-specific cells with a rate of 0.05 per hour (SE: 0.01), and returns as free virus with a rate of 0.11 per hour (SE: 0.02). Characterizing early HDV-host kinetics elucidates how quickly HDV is either cleared or bound depending on the immunological background and hNTCP presence. IMPORTANCE The persistence phase of HDV infection has been studied in some animal models; however, the early kinetics of HDV in vivo is incompletely understood. In this study, we characterize an unexpectedly HDV biphasic decline post-inoculation in immunocompetent and immunodeficient mouse models and use mathematical modeling to provide insights into HDV-host dynamics.https://journals.asm.org/doi/10.1128/mbio.01008-23viral hepatitishepatitis delta virushepatitis B virusmathematical modelinganimal model |
spellingShingle | Stephanie Maya Leeor Hershkovich E. Fabian Cardozo-Ojeda Elham Shirvani-Dastgerdi Jay Srinivas Louis Shekhtman Susan L. Uprichard Andrew R. Berneshawi Thomas R. Cafiero Harel Dahari Alexander Ploss Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic mBio viral hepatitis hepatitis delta virus hepatitis B virus mathematical modeling animal model |
title | Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic |
title_full | Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic |
title_fullStr | Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic |
title_full_unstemmed | Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic |
title_short | Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic |
title_sort | hepatitis delta virus rna decline post inoculation in human ntcp transgenic mice is biphasic |
topic | viral hepatitis hepatitis delta virus hepatitis B virus mathematical modeling animal model |
url | https://journals.asm.org/doi/10.1128/mbio.01008-23 |
work_keys_str_mv | AT stephaniemaya hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic AT leeorhershkovich hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic AT efabiancardozoojeda hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic AT elhamshirvanidastgerdi hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic AT jaysrinivas hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic AT louisshekhtman hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic AT susanluprichard hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic AT andrewrberneshawi hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic AT thomasrcafiero hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic AT hareldahari hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic AT alexanderploss hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic |